
Randomized Phase II Trial of the Cyclin-Dependent Kinase Inhibitor Dinaciclib (MK-7965) Versus Capecitabine in Patients With Advanced Breast Cancer
Keywords: تومورهای جامد; Efficacy; Monotherapy; Safety; Small-molecule inhibitor; Solid tumors;